Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2022

View Archived Issues

OR6A2 is a therapeutic target for atherosclerosis, researchers unveil

Novel ester prodrugs of E-selectin antagonists with improved PK properties

New ENPP2 inhibitors identified at Suzhou Ark Biopharmaceutical

New PROTACs targeting androgen receptors sythesized at Sichuan Haisco Pharmaceutical

Abbisko Therapeutics discovers EGFR inhibtors

Shenzhen Salubris Pharmaceuticals patents ADAM-TS 5 inhibitors

Vitalixir presents new antidiabetic polypeptides

Researchers identify COPA as a prognostic marker and therapeutic target in cervical cancer

Acute intermittent porphyria treatment targets recombinant PBGD protein to the liver

DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity

Novel CDK9 inhibitor inhibits osteosarcoma in patient-derived orthotopic xenografts

Loss of miR-15a/miR-16-1 contributes to CLL development

Ethris to advance mRNA-based therapeutics for respiratory diseases

Almirall signs agreements with Ablexis and AliviaMab to support work in dermatology

Celsion's DNA-based approach for SARS-CoV-2 vaccine to be studied in NHP challenge study

Drug cocktail is step up for leg regeneration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...